How does a phage-displayed cDNA library differ from a genomic library?

A cDNA library reflects expressed genes in a specific tissue or condition, excluding introns and regulatory elements. Genomic libraries include all DNA sequences but lack temporal or spatial resolution.

What kind of targets can I screen against using a cDNA library?

Our platform is highly versatile and can screen against a wide range of targets. This includes purified recombinant proteins, peptides, small molecules, cell surface markers on live cells (e.g., tumor cells, immune cells), and even complex mixtures like cell lysates or serum. The choice of target depends on your research objective.

What sample requirements apply?

Sample requirements: Tissue: ≥200 mg fresh/frozen. Cells: ≥5 × 107 viable cells. RNA: ≥500 μg (A260/A280 ≥1.8, RIN ≥8).

What is the typical library yield?

Primary libraries exceed 1 × 107 clones, with amplification achieving titers >1010 PFU/mL.

How are normalized libraries validated?

qPCR and transcriptome sequencing confirm ≥10× reduction in high-abundance mRNAs (e.g., ribosomal proteins).

Can you construct a library from a very small or difficult-to-obtain biological sample?

Yes. We have developed specialized protocols for RNA extraction and cDNA amplification from limited source material, such as small tissue biopsies or sorted cell populations. Our methods are optimized to yield sufficient high-quality cDNA for library construction. We will work with you during the consultation phase to assess the feasibility and required amount of starting material.

What is the final deliverable for this service?

The final deliverable includes a detailed report summarizing all experimental procedures and quality control results. The primary output is the identification of enriched clones, which are provided as a list of sequenced cDNA hits. For validated hits, we also provide the results of any binding assays or characterization studies.

cDNA Library Construction Service

Introduction Platform Services Cases Features Related Services FAQs Resources

Phage Display-Driven cDNA Library Introduction

The integration of phage display with cDNA libraries addresses critical challenges in functional proteomics. Conventional approaches often fail to express cytoplasmic or transmembrane proteins due to incompatibilities with prokaryotic secretion machinery. Innovations such as M13 phage-derived pIII/pVIII fusion systems, T7 phage display platform, and λ phage packaging strategies have expanded the scope of displayable proteins, including those requiring eukaryotic folding environments.

Fig 1. cDNA libraries construction by phage engineering. (Brišar, et al., 2024) (OA Literature) Fig. 1 cDNA libraries are constructed using phage engineering.¹

For instance, leucine zipper-mediated indirect display (e.g., cFos/cJun fusions) and pVI-C-terminal fusion systems bypass translational termination signals inherent in eukaryotic mRNAs, ensuring functional presentation of full-length cDNA products. As next-generation sequencing and machine learning refine library design and hit prioritization, phage-displayed cDNA libraries are poised to unlock novel therapeutic targets and diagnostic biomarkers, cementing their role as indispensable tools in precision medicine.

Turn Ideas into Discovery. Request a Consultation.

Phage Display Technology Platform

The foundation of our cDNA library construction service is that integrates high-efficiency molecular cloning with advanced biopanning and bioinformatic analysis. This platform is meticulously engineered to maximize library diversity and ensure the faithful representation of the source transcriptome.

Optimized cDNA Synthesis

We utilize advanced reverse transcription protocols to generate full-length, high-fidelity cDNA from minimal RNA input, a critical step for preserving the integrity of the expressed protein library. This includes robust methods for amplifying and normalizing cDNA to ensure even representation of both high- and low-abundance transcripts.

High-Efficiency Ligation and Transformation

Our proprietary ligation and electroporation protocols enable the generation of libraries with complexities exceeding 10⁹ independent clones. This scale is crucial for ensuring that even rare transcripts from the starting material are included in the final library, thus providing a comprehensive and unbiased representation of the proteome.

Stringent Quality Control

Every library undergoes a rigorous quality control process. We perform a series of assessments, including library size estimation via colony counting, insert size verification by PCR, and sequencing to confirm genetic diversity and integrity. This ensures that the library is of the highest quality and ready for downstream screening.

Integrated Screening and Analysis

The platform seamlessly integrates the library with various screening modalities. Our downstream capabilities, including sequencing-based quantification of enriched clones and subsequent bioinformatics analysis, allow for the rapid identification of a diverse set of binders. This integrated approach drastically reduces the time and resources typically required for traditional discovery workflows.

Build Your cDNA Library. Get Started Today.

End-to-End Solutions: From RNA to Functional Libraries

Creative Biolabs phage display-driven cDNA library construction service integrates cutting-edge molecular biology with customizable workflows to meet diverse research needs:

STEP	ITEM	DETAIL
Library Design & Construction	RNA to cDNA Synthesis	Utilizing SMART (Switching Mechanism at 5' End of RNA Template) technology, we convert 1 μg of total RNA into full-length cDNA, achieving >30% full-length inserts even from low-abundance transcripts.
	Vector Systems	Choose from M13 phage vectors. M13 pIII/pVIII fusions optimize surface display.
	Library Types	Standard Libraries: > 10⁸ clones, ideal for broad-spectrum screening. Normalized Libraries: DSN nuclease-mediated normalization reduces high-abundance transcripts by 10–100×, enhancing rare gene discovery. Subtractive Libraries: Tissue-specific mRNA enrichment for focused target identification
Quality Control & Validation	Titer Analysis	Ensure library complexity via plaque assays.
	Insert Characterization	Confirm average insert size and recombination efficiency through restriction digest and Sanger sequencing.
	Functional Screening	Optional biopanning services against immobilized targets (e.g., receptors, antibodies) to validate binding capacity.
Custom Solutions	Species-Specific Libraries	Tailored for plants, mammals, or pathogens.
Custom Solutions	Therapeutic Focus	Oncology (tumor antigen discovery), neuroscience (GPCR ligand screening), and infectious diseases (viral epitope mapping).

Accelerate Your Research. Talk to Our Experts.

Case Studies for Custom cDNA Library Construction

Overview	Objective	Build T7 phage display cDNA libraries from total RNA of two human cell lines (Sample 1 and Sample 2).
	Scope	RNA QC, cDNA synthesis, normalization, directional cloning into T7 system, packaging/amplification, and sequencing-based QC.
Workflow	Input QC → cDNA synthesis and normalization → size selection → directional cloning into T7 → library packaging and diversity-preserving amplification → QC
Outcomes	Both libraries successfully constructed and met acceptance criteria. High titer and diversity. Insert-positive rate >95%; insert sizes mainly 300-1,500 bp. Sequencing confirmed directional cloning, strong in-frame potential, and minimal rRNA/adapter carryover; no cross-sample contamination.
Deliverables	Ready-to-use packaged T7 phage libraries (primary and amplified stocks), plasmid pools, and a comprehensive QC report. Optional: raw/processed sequencing data.
Summary	Demonstrates our end-to-end capability to deliver high-diversity, display-ready T7 cDNA libraries with rigorous, sequencing-driven QC—accelerating downstream biopanning and discovery.

Unlock Phage Display Potential. Schedule a Call.

Service Advantages

High Diversity & Sensitivity

Achieve library capacities up to 10¹⁰ clones, ensuring coverage of even low-expressed transcripts.
SMART technology minimizes 5' mRNA degradation, preserving full-length coding sequences.

Versatile Display Systems

M13 Phage: Ideal for secreted proteins; pIII fusions support monovalent display for high-affinity binding.
T7 Phage: Cytoplasmic assembly bypasses secretion constraints; tolerant of stringent pH/salt/detergent conditions.

Scalability

Compatible with automated platforms for industrial-scale antibody or peptide discovery.

Phage display-based cDNA library construction bridges transcriptomic complexity with functional proteomics, empowering researchers to decode dynamic biological systems with unparalleled accuracy. Creative Biolabs speeds up the transition from initial gene discovery to therapeutic breakthroughs by leveraging scalable technology, strict quality control, and flexible design strategies.

Related Services

Custom Antibody Library Construction

Custom Peptide Library Construction

M13 Phage Library Construction

T4 Phage Library Construction

T7 Phage Library Construction

Genome Library Construction

FAQs

How does a phage-displayed cDNA library differ from a genomic library?
A cDNA library reflects expressed genes in a specific tissue or condition, excluding introns and regulatory elements. Genomic libraries include all DNA sequences but lack temporal or spatial resolution.
What kind of targets can I screen against using a cDNA library?
Our platform is highly versatile and can screen against a wide range of targets. This includes purified recombinant proteins, peptides, small molecules, cell surface markers on live cells (e.g., tumor cells, immune cells), and even complex mixtures like cell lysates or serum. The choice of target depends on your research objective.
What sample requirements apply?
Sample requirements:
Tissue: ≥200 mg fresh/frozen.
Cells: ≥5 × 107 viable cells.
RNA: ≥500 μg (A260/A280 ≥1.8, RIN ≥8).
What is the typical library yield?
Primary libraries exceed 1 × 10⁷ clones, with amplification achieving titers >10¹⁰ PFU/mL.
How are normalized libraries validated?
qPCR and transcriptome sequencing confirm ≥10× reduction in high-abundance mRNAs (e.g., ribosomal proteins).
Can you construct a library from a very small or difficult-to-obtain biological sample?
Yes. We have developed specialized protocols for RNA extraction and cDNA amplification from limited source material, such as small tissue biopsies or sorted cell populations. Our methods are optimized to yield sufficient high-quality cDNA for library construction. We will work with you during the consultation phase to assess the feasibility and required amount of starting material.
What is the final deliverable for this service?
The final deliverable includes a detailed report summarizing all experimental procedures and quality control results. The primary output is the identification of enriched clones, which are provided as a list of sequenced cDNA hits. For validated hits, we also provide the results of any binding assays or characterization studies.

Advance Your Science. Request Expert Support.

Resources

Use the resources in our library to help you understand your options and make critical decisions for your study.

VideosPodcastsInfographicFlyerCase studyArticles

Phage Display Technology

Antibody Library Screening

Phage Display Technology

Antibody Library Screening

Development of Monoclonal Antibodies

A Brief Introduction to Antibodies

Anti-idiotype Antibody Production

Phage Display Technology in Creative Biolabs

Antibody Development by Immune Phage Library

MemDX™ Therapeutic Antibody Discovery Platform

Antibody Development Case Study

Surface Display Overview

Phage Display Technology as a Powerful Platform for Antibody Drug Discovery

Basics of Antibody Phage Display Technology

Immune Antibody Phage Libraries for the Production of Antibodies to Infectious Diseases

Reference

Brišar, Nuša et al. "Preparation of Phage Display cDNA Libraries for Identifying Immunogenic Tumor Antigens: Challenges in Functional cDNA Presentation and Approaches to Overcoming Them." Viruses vol. 16,12 1855. 29 Nov. 2024, doi:10.3390/v16121855. Distributed under Open Access license CC BY 4.0, without modification.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: